SirPAD Analysis to Examine Sirolimus-Coated Balloon Treatment for Femoropopliteal Artery Disease #Sirolimus #BalloonAngioplasty #PeripheralArteryDisease #Femoropopliteal #PAD
SirPAD Analysis to Examine Sirolimus-Coated Balloon Treatment for Femoropopliteal Artery Disease
LAS VEGAS — A new analysis from the SirPAD randomised clinical trial will examine the use of a sirolimus-coated balloon in patients with femoropopliteal peripheral artery disease (PAD) and intermittent claudication, focusing on a group for whom treatment is intended to improve symptoms as well as prevent serious limb complications. The findings are scheduled to …
dlvr.it
September 24, 2026 at 6:34 PM
SirPAD Analysis to Examine Sirolimus-Coated Balloon Treatment for Femoropopliteal Artery Disease #Sirolimus #BalloonAngioplasty #PeripheralArteryDisease #Femoropopliteal #PAD
Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026#USA#Las_Vegas#Concept_Medical#SirPAD_Study#Femoropopliteal_PAD
Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026
The SirPAD study highlights significant results for patients with femoropopliteal arterial disease at VIVA 2026, presenting vital insights for effective treatment.
third-news.com
September 21, 2026 at 11:55 AM
Groundbreaking Findings on Femoropopliteal Arterial Disease Revealed at VIVA 2026#USA#Las_Vegas#Concept_Medical#SirPAD_Study#Femoropopliteal_PAD
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference#USA#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference
At the VIVA 2026 conference, the SirPAD study showcases significant findings on femoropopliteal artery disease treatments, enhancing patient outcomes.
third-news.com
September 21, 2026 at 11:10 AM
New Insights into Femoropopliteal Peripheral Artery Disease from SirPAD Study at VIVA 2026 Conference#USA#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026#United_States#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026
The SirPAD study at VIVA 2026 presents new insights on treating claudication due to femoropopliteal PAD, exploring the benefits of sirolimus-coated balloons.
third-news.com
September 21, 2026 at 8:24 AM
SirPAD Subgroup Study Highlights Innovative Treatment for Femoropopliteal PAD at VIVA 2026#United_States#Las_Vegas#Concept_Medical#MagicTouch_PTA#SirPAD_Study
New Insights Revealed at VIVA 2026 About Peripheral Artery Disease Treatments#USA#Las_Vegas#Concept_Medical#Peripheral_Artery_Disease#VIVA_Congress
New Insights Revealed at VIVA 2026 About Peripheral Artery Disease Treatments
At the VIVA 2026 congress, groundbreaking findings regarding femoropopliteal PAD treatments will be presented, offering hope for patients.
third-news.com
September 21, 2026 at 11:20 AM
New Insights Revealed at VIVA 2026 About Peripheral Artery Disease Treatments#USA#Las_Vegas#Concept_Medical#Peripheral_Artery_Disease#VIVA_Congress
From the latest issue: Sato and colleagues show that lipid-rich plaques identified by NIRS-IVUS are associated with worse 12-month limb outcomes after femoropopliteal endovascular therapy, highlighting #plaque composition as a key predictor of #MALE.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
July 30, 2026 at 1:30 PM
From the latest issue: Sato and colleagues show that lipid-rich plaques identified by NIRS-IVUS are associated with worse 12-month limb outcomes after femoropopliteal endovascular therapy, highlighting #plaque composition as a key predictor of #MALE.
journals.sagepub.com/doi/10.1177/...
journals.sagepub.com/doi/10.1177/...
Lecture 15: Peripheral Vascular Disease — Cardiovascular
Peripheral arterial disease represents atherosclerosis affecting non-coronary arteries, most commonly the lower extremities.
https://hibbertmed.com/lectures/year1/unit1.7_cardiovascular/lecture_15_peripheral_vascular_disease
Peripheral arterial disease represents atherosclerosis affecting non-coronary arteries, most commonly the lower extremities.
https://hibbertmed.com/lectures/year1/unit1.7_cardiovascular/lecture_15_peripheral_vascular_disease
February 20, 2026 at 5:33 PM
Lecture 15: Peripheral Vascular Disease — Cardiovascular
Peripheral arterial disease represents atherosclerosis affecting non-coronary arteries, most commonly the lower extremities.
https://hibbertmed.com/lectures/year1/unit1.7_cardiovascular/lecture_15_peripheral_vascular_disease
Peripheral arterial disease represents atherosclerosis affecting non-coronary arteries, most commonly the lower extremities.
https://hibbertmed.com/lectures/year1/unit1.7_cardiovascular/lecture_15_peripheral_vascular_disease
Drug-coated devices in CLTI
In a nationwide cohort of >100,000 patients undergoing femoropopliteal revascularisation, DCBs and DES were associated with lower risks of major amputation or death vs uncoated devices. #cardiosky
eurointervention.pcronline.com/article/safe...
In a nationwide cohort of >100,000 patients undergoing femoropopliteal revascularisation, DCBs and DES were associated with lower risks of major amputation or death vs uncoated devices. #cardiosky
eurointervention.pcronline.com/article/safe...
March 12, 2026 at 5:45 PM
Drug-coated devices in CLTI
In a nationwide cohort of >100,000 patients undergoing femoropopliteal revascularisation, DCBs and DES were associated with lower risks of major amputation or death vs uncoated devices. #cardiosky
eurointervention.pcronline.com/article/safe...
In a nationwide cohort of >100,000 patients undergoing femoropopliteal revascularisation, DCBs and DES were associated with lower risks of major amputation or death vs uncoated devices. #cardiosky
eurointervention.pcronline.com/article/safe...
Among patients who underwent femoropopliteal index interventions for claudication, endovascular procedures were associated with lower rates of major amputation at 1 year compared with open surgical bypass approaches.
ja.ma/3Waun9t
ja.ma/3Waun9t
October 16, 2025 at 7:45 PM
Among patients who underwent femoropopliteal index interventions for claudication, endovascular procedures were associated with lower rates of major amputation at 1 year compared with open surgical bypass approaches.
ja.ma/3Waun9t
ja.ma/3Waun9t
Missed it live? We’ve got you covered:
- Elegance 12-month results
- SPORTS 24-month outcomes
- Meta-analysis on femoropopliteal stenting
Leading voices in the field break it all down - don’t miss these insights.
Watch now: www.youtube.com/watch?v=gWaj...
- Elegance 12-month results
- SPORTS 24-month outcomes
- Meta-analysis on femoropopliteal stenting
Leading voices in the field break it all down - don’t miss these insights.
Watch now: www.youtube.com/watch?v=gWaj...
Drug Elution Data From Europe: A Review of Data Shown at LINC & Charing Cross
YouTube video by The VIVA Foundation
www.youtube.com
September 16, 2025 at 3:36 PM
Missed it live? We’ve got you covered:
- Elegance 12-month results
- SPORTS 24-month outcomes
- Meta-analysis on femoropopliteal stenting
Leading voices in the field break it all down - don’t miss these insights.
Watch now: www.youtube.com/watch?v=gWaj...
- Elegance 12-month results
- SPORTS 24-month outcomes
- Meta-analysis on femoropopliteal stenting
Leading voices in the field break it all down - don’t miss these insights.
Watch now: www.youtube.com/watch?v=gWaj...
Happening tonight: the newest PAD trial results in one focused hour.
✔ 12-month Elegance
✔ 24-month SPORTS
✔ New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.
Register now: viva-foundation.org/webinar-regi...
✔ 12-month Elegance
✔ 24-month SPORTS
✔ New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.
Register now: viva-foundation.org/webinar-regi...
September 3, 2025 at 4:04 PM
Happening tonight: the newest PAD trial results in one focused hour.
✔ 12-month Elegance
✔ 24-month SPORTS
✔ New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.
Register now: viva-foundation.org/webinar-regi...
✔ 12-month Elegance
✔ 24-month SPORTS
✔ New femoropopliteal meta-analysis
Live expert discussion on data debuted at LINC & CX.
Register now: viva-foundation.org/webinar-regi...
Happy Tuesday! See this week's featured data from #VIVA24: Final Results of the DETOUR2 Study: Durability of Percutaneous Transmural Arterial Bypass for Treatment of Complex Femoropopliteal Disease presented by Dr. Sean Lyden
youtu.be/ia2J8yxEB28
youtu.be/ia2J8yxEB28
VIVA24 Late-Breaking Clinical Trial: Final Results of the DETOUR2 Study
YouTube video by The VIVA Foundation
youtu.be
April 15, 2025 at 1:28 PM
Happy Tuesday! See this week's featured data from #VIVA24: Final Results of the DETOUR2 Study: Durability of Percutaneous Transmural Arterial Bypass for Treatment of Complex Femoropopliteal Disease presented by Dr. Sean Lyden
youtu.be/ia2J8yxEB28
youtu.be/ia2J8yxEB28
#CIRSE2025 is on the horizon!
As you prepare for the IR congress of the year, don’t miss Prof. Stavros Spiliopoulos’ sneak peek into his lecture on vessel preparation using scoring balloons for the treatment of femoropopliteal arterial lesions.
👉 t.ly/DzMgX
➡️Register with the early fee: t.ly/iGdD5
As you prepare for the IR congress of the year, don’t miss Prof. Stavros Spiliopoulos’ sneak peek into his lecture on vessel preparation using scoring balloons for the treatment of femoropopliteal arterial lesions.
👉 t.ly/DzMgX
➡️Register with the early fee: t.ly/iGdD5
July 2, 2025 at 7:38 AM
#CIRSE2025 is on the horizon!
As you prepare for the IR congress of the year, don’t miss Prof. Stavros Spiliopoulos’ sneak peek into his lecture on vessel preparation using scoring balloons for the treatment of femoropopliteal arterial lesions.
👉 t.ly/DzMgX
➡️Register with the early fee: t.ly/iGdD5
As you prepare for the IR congress of the year, don’t miss Prof. Stavros Spiliopoulos’ sneak peek into his lecture on vessel preparation using scoring balloons for the treatment of femoropopliteal arterial lesions.
👉 t.ly/DzMgX
➡️Register with the early fee: t.ly/iGdD5
Drug Coated Balloon Angioplasty after Plain or Scoring Balloon for Vessel Preparation for Femoropopliteal Arterial Disease (DASBAD): A Randomised Controlled Trial www.sciencedirect.com/science/arti... #hvhebron #cv [Text complet]
Drug Coated Balloon Angioplasty after Plain or Scoring Balloon for Vessel Preparation for Femoropopliteal Arterial Disease (DASBAD): A Randomised Controlled Trial
Plain balloon angioplasty (PBA) remains the standard technique for vessel preparation in peripheral artery disease. This prospective, single centre, s…
www.sciencedirect.com
June 10, 2026 at 5:18 PM
Drug Coated Balloon Angioplasty after Plain or Scoring Balloon for Vessel Preparation for Femoropopliteal Arterial Disease (DASBAD): A Randomised Controlled Trial www.sciencedirect.com/science/arti... #hvhebron #cv [Text complet]
Online first: Sato and colleagues show that lipid-rich plaques identified by NIRS-IVUS are associated with worse 12-month limb outcomes after femoropopliteal endovascular therapy, highlighting plaque composition as a key predictor of MALE.
doi.org/10.1177/1358...
doi.org/10.1177/1358...
May 12, 2026 at 1:15 PM
Online first: Sato and colleagues show that lipid-rich plaques identified by NIRS-IVUS are associated with worse 12-month limb outcomes after femoropopliteal endovascular therapy, highlighting plaque composition as a key predictor of MALE.
doi.org/10.1177/1358...
doi.org/10.1177/1358...
From the latest issue:
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
doi.org
November 14, 2025 at 10:01 PM
From the latest issue:
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
Online First!
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
doi.org
October 7, 2025 at 10:30 PM
Online First!
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
Sachar and colleagues report the long-term results of the Ranger II SFA randomized trial, comparing a low-dose paclitaxel drug-coated balloon with standard angioplasty for femoropopliteal artery stenosis.
🔗 doi.org/10.1177/1358...
#PAD #Atherosclerosis
From the latest issue: Yoshioka and colleagues share data on recurrence patterns and clinical outcomes following paclitaxel-coated balloon angioplasty in patients with femoropopliteal artery disease.
journals.sagepub.com/doi/full/10....
#PeripheralArteryDisease
journals.sagepub.com/doi/full/10....
#PeripheralArteryDisease
September 4, 2025 at 10:00 PM
From the latest issue: Yoshioka and colleagues share data on recurrence patterns and clinical outcomes following paclitaxel-coated balloon angioplasty in patients with femoropopliteal artery disease.
journals.sagepub.com/doi/full/10....
#PeripheralArteryDisease
journals.sagepub.com/doi/full/10....
#PeripheralArteryDisease
From the latest issue: Does coverage of the deep femoral artery during endovascular treatment for ostial femoropopliteal lesions result in adverse patient outcomes? Tokuda and colleagues share their data.
buff.ly/4hN9j1K
#Peripheralarterydisease #CardioSky #VascSky
buff.ly/4hN9j1K
#Peripheralarterydisease #CardioSky #VascSky
May 2, 2025 at 11:30 PM
From the latest issue: Does coverage of the deep femoral artery during endovascular treatment for ostial femoropopliteal lesions result in adverse patient outcomes? Tokuda and colleagues share their data.
buff.ly/4hN9j1K
#Peripheralarterydisease #CardioSky #VascSky
buff.ly/4hN9j1K
#Peripheralarterydisease #CardioSky #VascSky
Online First! Does coverage of the deep femoral artery during endovascular treatment for ostial femoropopliteal lesions result in adverse patient outcomes? Tokuda and colleagues share their data.
https://buff.ly/4hN9j1K
#Peripheralarterydisease
https://buff.ly/4hN9j1K
#Peripheralarterydisease
February 6, 2025 at 11:00 PM
Online First! Does coverage of the deep femoral artery during endovascular treatment for ostial femoropopliteal lesions result in adverse patient outcomes? Tokuda and colleagues share their data.
https://buff.ly/4hN9j1K
#Peripheralarterydisease
https://buff.ly/4hN9j1K
#Peripheralarterydisease
Optimizing stent design for the femoropopliteal artery addresses critical cardiovascular challenges and enhances patient treatment outcomes, showcasing the intersection of healthcare and design.
bioengineer.org/optimizing-s...
bioengineer.org/optimizing-s...
Optimizing Stent Design for Femoropopliteal Artery
A groundbreaking study has emerged in the field of biomedical engineering, focusing on the optimization of stent design specifically for the femoropopliteal artery. The research, conducted by a team
bioengineer.org
January 17, 2026 at 12:39 AM
Optimizing stent design for the femoropopliteal artery addresses critical cardiovascular challenges and enhances patient treatment outcomes, showcasing the intersection of healthcare and design.
bioengineer.org/optimizing-s...
bioengineer.org/optimizing-s...
Member publication alert:
Computational Optimization of a Stent for the Femoropopliteal Artery
link.springer.com/article/10.1...
Computational Optimization of a Stent for the Femoropopliteal Artery
link.springer.com/article/10.1...
Computational Optimization of a Stent for the Femoropopliteal Artery - Annals of Biomedical Engineering
Purpose Clinical outcomes of peripheral artery disease (PAD) stenting, particularly in the highly dynamic regions of the femoropopliteal artery at the adductor hiatus and behind the knee, leave signif...
link.springer.com
January 18, 2026 at 8:15 PM
Member publication alert:
Computational Optimization of a Stent for the Femoropopliteal Artery
link.springer.com/article/10.1...
Computational Optimization of a Stent for the Femoropopliteal Artery
link.springer.com/article/10.1...
Member publication alert:
Differential effects of demographics and risk factors on the nonlinear orthotropic mechanical properties of human femoropopliteal arteries
link.springer.com/article/10.1...
Differential effects of demographics and risk factors on the nonlinear orthotropic mechanical properties of human femoropopliteal arteries
link.springer.com/article/10.1...
Differential effects of demographics and risk factors on the nonlinear orthotropic mechanical properties of human femoropopliteal arteries - Biomechanics and Modeling in Mechanobiology
Understanding how demographics and risk factors differentially affect the nonlinear orthotropic mechanical properties of human femoropopliteal arteries (FPAs) is critical for improving computational m...
link.springer.com
August 4, 2025 at 6:39 PM
Member publication alert:
Differential effects of demographics and risk factors on the nonlinear orthotropic mechanical properties of human femoropopliteal arteries
link.springer.com/article/10.1...
Differential effects of demographics and risk factors on the nonlinear orthotropic mechanical properties of human femoropopliteal arteries
link.springer.com/article/10.1...
Feed: "BIOENGINEER.ORG"
By: Bioengineer on Saturday, November 1, 2025
By: Bioengineer on Saturday, November 1, 2025
Assessing Femoropopliteal Arteries: Health vs. Revascularization
In a groundbreaking study, researchers led by Gostev, Osipova, and Volkova have unveiled new insights into the biomechanical properties of femoropopliteal arteries—vital conduits in the circulatory s
bioengineer.org
November 1, 2025 at 7:07 PM
Feed: "BIOENGINEER.ORG"
By: Bioengineer on Saturday, November 1, 2025
By: Bioengineer on Saturday, November 1, 2025
Bone in an Artery!😍
A beautiful histopathologic study on #MedialCalcification & #IntimalCalcification Lower Limb Arteries
> 2k sections, 77 (femoropopliteal/anterior tibial/posterior tibial/peroneal/) arteries, 36 #LimbIschemia👤
Sho Torii lab 2024 #JACCAdv
www.sciencedirect.com/science/arti...
A beautiful histopathologic study on #MedialCalcification & #IntimalCalcification Lower Limb Arteries
> 2k sections, 77 (femoropopliteal/anterior tibial/posterior tibial/peroneal/) arteries, 36 #LimbIschemia👤
Sho Torii lab 2024 #JACCAdv
www.sciencedirect.com/science/arti...
June 30, 2024 at 7:08 PM
Bone in an Artery!😍
A beautiful histopathologic study on #MedialCalcification & #IntimalCalcification Lower Limb Arteries
> 2k sections, 77 (femoropopliteal/anterior tibial/posterior tibial/peroneal/) arteries, 36 #LimbIschemia👤
Sho Torii lab 2024 #JACCAdv
www.sciencedirect.com/science/arti...
A beautiful histopathologic study on #MedialCalcification & #IntimalCalcification Lower Limb Arteries
> 2k sections, 77 (femoropopliteal/anterior tibial/posterior tibial/peroneal/) arteries, 36 #LimbIschemia👤
Sho Torii lab 2024 #JACCAdv
www.sciencedirect.com/science/arti...